$13.7 Million is the total value of CROSBY Co OF NEW HAMPSHIRE LLC's 1 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RMD | Sell | RESMED INC | $13,653,000 | +16.9% | 111,883 | -0.4% | 100.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| 0 | 23 | Q2 2024 | 0.0% |
| 0 | 11 | Q3 2016 | 0.0% |
| RESMED INC | 7 | Q2 2019 | 100.0% |
| 1LIFE HEALTHCARE INC | 1 | Q3 2022 | 100.0% |
| ACTAVIS PLC | 1 | Q2 2014 | 49.6% |
| GENERAC HOLDINGS INC | 1 | Q2 2014 | 21.5% |
| HENRY SCHEIN INC COM | 1 | Q2 2014 | 16.4% |
| DANAHER CORP | 1 | Q2 2014 | 10.6% |
| WESCO INTERNATIONAL | 1 | Q2 2014 | 0.4% |
| CONCHO RESOURCES INC | 1 | Q2 2014 | 0.3% |
View CROSBY Co OF NEW HAMPSHIRE LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-23 |
| 13F-HR | 2024-08-09 |
| 13F-HR | 2024-05-10 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View CROSBY Co OF NEW HAMPSHIRE LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.